0.08
-0.002(-2.50%)
Currency In USD
| Previous Close | 0.08 |
| Open | 0.07 |
| Day High | 0.08 |
| Day Low | 0.07 |
| 52-Week High | 14 |
| 52-Week Low | 0.05 |
| Volume | 2.19M |
| Average Volume | 22.16M |
| Market Cap | 3.46M |
| PE | 0 |
| EPS | -87.25 |
| Moving Average 50 Days | 0.08 |
| Moving Average 200 Days | 1.78 |
| Change | -0 |
If you invested $1000 in Onconetix, Inc. (ONCO) since IPO date, it would be worth $0.03 as of June 01, 2025 at a share price of $0.078. Whereas If you bought $1000 worth of Onconetix, Inc. (ONCO) shares 2 years ago, it would be worth $2.44 as of June 01, 2025 at a share price of $0.078.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CSE Bulletin: Delist - Onco-Innovations Limited (ONCO)
Newsfile
May 20, 2025 5:09 PM GMT
Toronto, Ontario--(Newsfile Corp. - Le 20 mai/May 2025) - The common shares of Onco-Innovations Limited will be delisted from the CSE at market close, May 21, 2025. Onco-Innovations Limited will continue to trade on Cboe. ______
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
GlobeNewswire Inc.
Apr 30, 2025 10:13 PM GMT
Cincinnati, OH, April 30, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq”) on April 24, 2025 indicating that the Company’s failure
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
GlobeNewswire Inc.
Apr 08, 2025 12:30 PM GMT
CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) (formerly Blue Water Biotech Inc.) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the dev